William Blair & Company’s Cardiff Oncology CRDF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95M | Buy |
2,524,118
+772,844
| +44% | +$2.43M | 0.02% | 398 |
|
|
2025
Q1 | $5.5M | Buy |
1,751,274
+1,469,249
| +521% | +$4.61M | 0.02% | 461 |
|
|
2024
Q4 | $1.22M | Buy |
282,025
+34,947
| +14% | +$152K | ﹤0.01% | 831 |
|
|
2024
Q3 | $660K | Buy |
247,078
+19,448
| +9% | +$51.9K | ﹤0.01% | 1039 |
|
|
2024
Q2 | $505K | Buy |
227,630
+55,450
| +32% | +$123K | ﹤0.01% | 1096 |
|
|
2024
Q1 | $919K | Buy |
172,180
+42,180
| +32% | +$225K | ﹤0.01% | 897 |
|
|
2023
Q4 | $192K | Sell |
130,000
-500
| -0.4% | -$740 | ﹤0.01% | 1410 |
|
|
2023
Q3 | $181K | Hold |
130,500
| – | – | ﹤0.01% | 1408 |
|
|
2023
Q2 | $192K | Hold |
130,500
| – | – | ﹤0.01% | 1416 |
|
|
2023
Q1 | $215K | Sell |
130,500
-21,075
| -14% | -$34.8K | ﹤0.01% | 1377 |
|
|
2022
Q4 | $212K | Sell |
151,575
-18,000
| -11% | -$25.2K | ﹤0.01% | 1349 |
|
|
2022
Q3 | $261K | Buy |
169,575
+37,000
| +28% | +$56.9K | ﹤0.01% | 1283 |
|
|
2022
Q2 | $292K | Buy |
132,575
+42,700
| +48% | +$94K | ﹤0.01% | 1283 |
|
|
2022
Q1 | $223K | Sell |
89,875
-117,615
| -57% | -$292K | ﹤0.01% | 1479 |
|
|
2021
Q4 | $1.25M | Sell |
207,490
-3,270
| -2% | -$19.7K | ﹤0.01% | 886 |
|
|
2021
Q3 | $1.4M | Buy |
+210,760
| New | +$1.4M | ﹤0.01% | 798 |
|